{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 447984244
| IUPAC_name = [(1-benzyl-1''H''-indazol-3-yl)oxy]acetic acid
| image = Bendazac.svg
<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|international|bendazac}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!--             / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->
| legal_US = <!-- OTC                   / Rx-only  / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration = Topical
<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  
<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 20187-55-7
| ATC_prefix = M02
| ATC_suffix = AA11
| ATC_supplemental = {{ATC|S01|BC07}}
| PubChem = 2313
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 2223
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = G4AG71204O
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D01594
| ChEBI_Ref = {{ebicite|changed|EBI}}
| ChEBI = 31257
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 1089221
<!--Chemical data-->
| C=16 | H=14
| N=2 | O=3
| molecular_weight = 282.294 g/mol
| smiles = O=C(O)COc2nn(c1ccccc12)Cc3ccccc3
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C16H14N2O3/c19-15(20)11-21-16-13-8-4-5-9-14(13)18(17-16)10-12-6-2-1-3-7-12/h1-9H,10-11H2,(H,19,20)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = BYFMCKSPFYVMOU-UHFFFAOYSA-N
}}

'''Bendazac''' (or '''bendazolic acid''') is a [[nonsteroidal anti-inflammatory drug]] (NSAID) used for joint and muscular pain.

==Synthesis==
Principal action is inhibition of protein denaturation.
[[File:Bendazac synthesis.svg|thumb|center|700px|Bendazac synthesis: {{Cite patent|BE|699226}}; G. Palazzo, {{US patent|3470194}} (1967, 1969 both to [[Francesco Angelini]]).]]
Use of [[chloroacetamide]] in the alkylation step, followed by acid hydrolysis produces bendazac (instead of [[benzydamine]]).

==See also==
* [[Benzydamine]]

==References==
{{Reflist|2}}


{{NSAIDs}}
{{Topical products for joint and muscular pain}}
{{Prostanoidergics}}

[[Category:Hepatotoxins]]
[[Category:Nonsteroidal anti-inflammatory drugs]]


{{musculoskeletal-drug-stub}}
{{analgesic-stub}}